GREEN VISION BIOTECHNOLOGY CORP. — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$145.1K

Net Income/Loss (FY2021)

-$499.8K

Total Assets (FY2021)

$2.9M

Total Equity (FY2021)

-$7.9M

Cash Flows from Operating Activities (FY2021)

-$235.3K

Source: GREEN VISION BIOTECHNOLOGY CORP. 10-K/A filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.